The impact of body mass index on serum androgen and leptin association in reproductive age women

  • Sanaa Al-Mandalawi --------- Department of Clinical Analysis, College of Pharmacy, Hawler Medical University, Erbil, Iraq.
  • Mahdy Ahmed Khzer Department of Lab. Analysis, Rizgaree Teaching Hospital, Directorate of Health, Erbil, Iraq.
Keywords: androstenedione, leptin, free testosterone

Abstract

Background and objective: Obesity has been associated with increased androgenicity in women. There are, however, major inconsistencies in available data concerning the possible association between androgenicity and leptin in humans.The objectives of this study were to evaluate the impact of body mass index on androgens and the potential contribution of leptin in determination of androgen levels in women.

Methods: The study included 80 healthy females with an established Body Mass Index (BMI). They were divided into 4 groups. First group, 30 normal weight subjects (BMI<25 Kg/m2), second group, 25 overweight subjects (BMI=25–29.9 Kg/m2) , third group,15 obese grade-I subjects (BMI=30–34.9 Kg/m2) and forth group, 10 obese grade-II subjects (BMI>35 Kg/m2). Serum, leptin, free testosterone, androstenedione, glucose, lipid profile and body mass index were measured.

Results: There was no statistically significant difference in median serum androstenedione, while free testosterone was significantly lower (14.5 pg/ml) in obese grade II and higher in normal weight (60 pg/ml) and statistically significant increase in serum leptin with increase in body mass index. Serum free testosterone was lower (23.5 pg/ml) in subjects with highest quartile serum leptin and higher (43pg/ml), in subjects with lowest quartile serum leptin, the difference was not significant statistically.

Conclusion: high body mass index negatively influence the circulating free testosterone in reproductive age women. An inverse association between circulating leptin and free testosterone was observed

References

Taponen S, Martikainen H, Jarvelin MR, Laitinen J, Pouta A, Hartikainen AL, Sovio U. Hormonal profile of women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland Birth Cohort Study. J Clin Endocrinol and Metab 2003; 88 :141–7.

Holte J, Bergh T, Gennarelli G , Wide L. The nindependent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clin Endocrinol 1994; 41: 473–81.

Somdat M, David JB, Laura L, Terry J, Hartman J F. Usefulness of Body Mass Index as a Sufficient Adiposity Measurement for Sex Hormone Concentration Associations in Postmenopausal Women. Cancer Epidemiol Biomarkers Prev 2006;15(12):2502–7

Adamski J , Jakob FJ. A guide to 17_-hydroxysteroid dehydrogenases. Molec cellu Endocrinol 2001; 171: 1–4.

Luu-The V. Analysis and characteristics of multiple types of human 17_-hydroxysteroid dehydrogenase. J of Steroid Biochemist and Molec Biolo 2001;76 :143–51.

Marcus Q, Binayak S, Jeremy W , Iwona J B, Paul M S ,Wiebke A. Androgen generation in adipose tissue in women with simple obesity – a site-specific role for 17_-hydroxysteroid dehydrogenase type 5. J of Endocrinol 2004; 183: 331–42

John E, Morley H, Mitchell P. Androgens and Women at the Menopause and Beyond. J Gerontol 2003; 58A (5):409-16.

Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425 - 32.

Bray GA, York DA. Leptin and clinical medicine: a new piece in the puzzle of obesity. J Clin Endocrinol Metab 1997; 82: 2771 - 76.

Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos- Flier E. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382: 252 - 9.

Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR . Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New Engl J Med 1996; 334: 292 - 5.

Wabitsch M, Blum WF, Muche R, Braun M, Hube F, Rascher W, Heinze E, Teller W. Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J Clin Invest 1997; 100: 808 - 13.

Blum WF, Englaro P, Hanitsch S, Juul A, Hertel NT, Muller J, Skakkebaek NE. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender,pubertal stage, and testosterone. J Clin Endocrinol Metab 1997; 82:2904-10.

SoEderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K. Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999; 246: 409 - 18.

SoEderberg S, AhreÂn B, Stegmayr B, Johnson Finland Birth Cohort Study. J Clin Endocrinol and Metab 2003; 88 :141–7.

Holte J, Bergh T, Gennarelli G , Wide L. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clin Endocrinol 1994; 41: 473–81.

Somdat M, David JB, Laura L, Terry J, Hartman J F. Usefulness of Body Mass Index as a Sufficient Adiposity Measurement for Sex Hormone Concentration Associations in Postmenopausal Women. Cancer Epidemiol Biomarkers Prev 2006;15(12):2502–7

Adamski J , Jakob FJ. A guide to 17_-hydroxysteroid dehydrogenases. Molec cellu Endocrinol 2001; 171: 1–4.

Luu-The V. Analysis and characteristics of multiple types of human 17_-hydroxysteroid dehydrogenase. J of Steroid Biochemist and Molec Biolo 2001;76 :143–51.

Marcus Q, Binayak S, Jeremy W, Iwona J B, Paul M S ,Wiebke A. Androgen generation in adipose tissue in women with simple obesity – a site-specific role for 17_-hydroxysteroid dehydrogenase type 5. J of Endocrinol 2004; 183: 331–42

John E, Morley H, Mitchell P. Androgens and Women at the Menopause and Beyond. J Gerontol 2003; 58A (5):409-16.

Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425 - 32.

Bray GA, York DA. Leptin and clinical medicine: a new piece in the puzzle of obesity. J Clin Endocrinol Metab 1997; 82: 2771 - 76.

Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos- Flier E. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382: 252 - 9.

Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR . Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New Engl J Med 1996; 334: 292 - 5.

Wabitsch M, Blum WF, Muche R, Braun M, Hube F, Rascher W, Heinze E, Teller W. Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J Clin Invest 1997; 100: 808 - 13.

Blum WF, Englaro P, Hanitsch S, Juul A, Hertel NT, Muller J, Skakkebaek NE. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender,pubertal stage, and testosterone. J Clin Endocrinol Metab 1997; 82:2904-10.

SoEderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K. Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999; 246: 409 - 18.

SoEderberg S, AhreÂn B, Stegmayr B, Johnson

Mantzoros CS, Bolhke K, Moschos S, Cramer DW. Leptin in relation to carcinoma in situ of the breast: A study of pre-menopausal women. Int J Cancer 1999; 80:523-6.

Petridou E, Padadiamantis Y, Markopoulos C, Spanos E, Dessypris N, Trichopoulos D: Leptin and insulin growth factor I in relation to breast cancer (Greece).Cancer Causes and Control 2000;1:383-8.

Stattin P, Soderberg S, Biessy C, Lenner P, Hallmans G, Kaaks R, Olsson T.Plasma leptin and breast cancer risk: a prospective study in northern Sweden. Breast Cancer Res Treat 2004; 86: 191-6.

Ivandic A, Prpic-Krizevac I, Sucic M , Juric M. Hyperinsulinemia and sex hormones in healthy premenopausal women: relative contribution of obesity, obesity type, and duration of obesity. Metabolism 1998; 47:13–19.

Dorgan JF, Reichman ME, Judd JT, Brown C, Longcope C, Schatzkin A . The relation of body size to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States). Cancer Causes and Control 1995; 6: 3–8.

Madigan MP, Troisi R, Potischman N, Dorgan JF, Brinton LA ,Hoover RN. Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States). Cancer Causes and Control 1998 ;9 :199–207.

Kirschner MA, Samojlik E, Drejka M, Szmal E, Schneider G , Ertel N. Androgen–estrogen metabolism in women with upper body versus lower body obesity. J Clin Endocrinol Metab 1990; 70: 473–9.

Bernasconi D, Del Monte P, Meozzi M, Randazzo M, Marugo A, Badaracco B . The impact of obesity on hormonal parameters in hirsute and non hirsute women. Metabolism 1996; 45: 72–5.

Bernini GP, Moretti A, Sgro M, Argenio GF, Barlascini CO, Cristofani R, Salvetti A.Influence of endogenous androgens on carotid wall in postmenopausal women. Menopause 2001; 8:43-50.

Maravelias C, Dona A, Stefanidou M, Spiliopoulou C. Adverse effects of anabolic steroids in athletes. A constant threat. Toxicol Lett 2005;158:167-75.

Bergh C, Carlsson B, Olsson JH, Selleskog U , Hillensjo T. Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil and Steril 1993; 59: 323–31.

McGee EA, Sawetawan C, Bird I, Rainey WE ,Carr BR. The effect of insulin and insulin-like growth factors on the expression of steroidogenic enzymes in a human ovarian thecal-like tumor cell model. Fertil and Steril 1996; 65: 87–93.

Sowers J. Beebe D. McConnell L, John R, Jannausch M. Testosterone Concentrations in Women Aged 25–50 Years: Associations with Lifestyle, Body Composition, and Ovarian Status. Am J Epidemiol 2001;153:256–64.

Jockenhovel F, Blum WF, Vogel E, Englaro P, Muller-Wieland D, Reinwein D, Rascher W. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. J Clin Endocrinol Metab 1997; 82: 2510 - 13.

Sih R, Morley JE, Kaiser FE, Perry HM, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12- month randomized controlled trial. J Clin Endocrinol Metab 1997; 82: 1661 -67.

Luukkaa V, Pesonen U, Huhtaniemi I, Lehtonen A, Tilvis R, Tuomilehto J, Koulu M, Huupponen R. Inverse correlation between serum testosterone and leptin in men. J Clin Endocrinol Metab 1998; 83: 3243 - 46.

Arslanian S, Suprasongsin C. Testosterone treatment in adolescents with delayed puberty: changes in body composition, protein, fat, and glucose metabolism. J Clin Endocrinol Metab 1997; 82: 3213 - 20.

Elbers JM, Asscheman H, Seidell JC, Frolich M, Meinders AE, Gooren LJ. Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals. J Clin Endocrinol Metab 1997; 82: 3267 - 70.

Published
2018-10-07
How to Cite
---------, S., & Khzer, M. (2018). The impact of body mass index on serum androgen and leptin association in reproductive age women. Zanco Journal of Medical Sciences (Zanco J Med Sci), 17(3), 539 - 548. https://doi.org/10.15218/zjms.2013.0046
Section
Original Articles